Jyotiraditya Scindia issues action plan for better crowd management at airports

Passengers have been complaining on social media of crowding and chaos at major international airports in the country since December 1, when a new set of travel rules were imposed amid concerns over the Omicron variant of the coronavirus.

PTI

December 10, 2021 / 18:47 IST

Representative image: AP

Civil Aviation Minister Jyotiraditya Scindia on Tuesday said he has issued an action plan for better crowd management at airports across the country which includes expanding RT-PCR test services and ramping up forex counters.

Passengers have been complaining on social media of crowding and chaos at major international airports in the country since December 1, when a new set of travel rules were imposed amid concerns over the Omicron variant of the coronavirus.

ALSO READ: Airports are congested, but traffic isn’t at pre-Covid levels. What gives?

Taking to Twitter, Scindia said, "Took stock of the preparedness, testing capacities, and the situation on the ground with regard to crowd management at both private and AAI airports." The Airports Authority of India (AAI) controls more than 100 airports across the country. However, major airports such as in Delhi, Mumbai, Bengaluru, Hyderabad and Ahmedabad are operated by private entities.

The minister said he has put in place "an action plan with eight compliances on immigration queues, expanding RT-PCR service providers, ramping up help desks and forex counters, along with seamless floor management". Rest assured, the aviation ministry is monitoring the situation on a daily basis and passengers should not face any inconvenience at airports, he added.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show